We are highlighted in Part II, which explores Switzerland’s emphasis on new technology and its leadership in addressing global health challenges. A recent McKinsey report reveals that women experience 25% more time in ‘poor health’ compared to men. Switzerland has made significant investments in this field, establishing itself as a leading hub for women’s health, with over 30 specialized companies already operating in the country.

Our mission at WBF is to transform the development of drugs and medical treatments through sex and gender factors as a gateway to precision medicine and care. We are actively searching for partners and sponsors for our research to establish the first research institute for sex and gender precision medicine in Switzerland. 

Read the full articles:
Part I 
Part II